Home/Filings/4/0001209191-15-084774
4//SEC Filing

TREVENA INC 4

Accession 0001209191-15-084774

CIK 0001429560operating

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 5:17 PM ET

Size

5.3 KB

Accession

0001209191-15-084774

Insider Transaction Report

Form 4
Period: 2015-12-10
Soergel David
Sr. VP, Clinical Development
Transactions
  • Sale

    Common Stock

    2015-12-10$10.55/sh27,217$287,1391,750 total
Footnotes (2)
  • [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 23, 2015.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in several transactions at prices ranging from $10.13 - $10.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Issuer

TREVENA INC

CIK 0001429560

Entity typeoperating

Related Parties

1
  • filerCIK 0001429560

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:17 PM ET
Size
5.3 KB